Board Chairman
Jason Cleveland became Chairperson of the QDTI board in 2024. He has over 30 years of experience as a technology innovator in scientific instruments and proteomic assays. He was most recently at SomaLogic, a proteomics company with an assay measuring 10,000 proteins, where he was CTO. Prior to joining SomaLogic, Dr. Cleveland was the co-founder, chairman and later, CEO of Asylum Research in Santa Barbara, California, a manufacturer of atomic force microscopes founded in 1999 and sold to Oxford Instruments in 2012. As a hands-on CEO, he was heavily involved in designing the Cypher AFM, which is still the quietest, fastest and most stable research atomic force microscope in the world, with an installed base of more than 1,000 instruments. He began his career at Digital Instruments, the largest atomic force microscope company at the time. Dr. Cleveland has a doctorate in physics from the University of California, Santa Barbara, and a bachelor’s degree in math and physics from the University of Minnesota, where he was a Goldwater Scholar. He is a fellow of the American Physical Society, an author of over 40 scientific publications with an h-index of 30, and an inventor on over 50 patents. He also serves as chairman of DE-CRUIT, a non-profit treating trauma in veterans through Shakespeare and science.
